Skip to main content
Year archive

XTL Biopharmaceuticals Ltd. — 2020 filings

All 36 regulatory filings released by XTL Biopharmaceuticals Ltd. (XTLB) in 2020, sourced directly from the official regulator.

36 Filings
2020 Period
2020 filings (36)
Filing Released Lang
postponement of annual meeting to January 1st, 2021-No legal quorum
AGM Information
2020-12-31 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-12-31 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2020
AGM Information
2020-11-25 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2020
AGM Information
2020-11-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-11-25 English
6K: Financial results for the nine months ended September 30, 2020
Earnings Release 9M 2020
2020-11-12 English
6K: Financial results for the nine months ended September 30, 2020
Report Publication Announcement
2020-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-11-12 English
Financial results for the six months period ended June 30, 2020
Interim / Quarterly Report H1 2020
2020-08-24 English
Financial results for the six months period ended June 30, 2020
Report Publication Announcement H1 2020
2020-08-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-08-24 English
results of the Extraordinary General Meeting of shareholders of the Company, Tuesday, July 7, 2020
AGM Information
2020-07-07 English
results of the Extraordinary General Meeting of shareholders of the Company, Tuesday, July 7, 2020
Report Publication Announcement
2020-07-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-07-07 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2020-06-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-06-30 English
Financial results for the quarter ended March 31, 2020.
Earnings Release Q1 2020
2020-05-27 English
Financial results for the quarter ended March 31, 2020.
Report Publication Announcement
2020-05-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-05-27 English
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 30, 2020
Proxy Solicitation & Information Statement
2020-05-26 English
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 30, 2020
Proxy Solicitation & Information Statement
2020-05-26 English
The board of directors appointed Shlomo Shalev to serve as Chief Executive Officer of the Company
Board/Management Information
2020-05-26 English
The board of directors appointed Shlomo Shalev to serve as Chief Executive Officer of the Company
Report Publication Announcement
2020-05-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-05-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-05-26 English
Annual Report - Form 20-F 2019
Annual Report FY 2019
2020-03-12 English
Annual Report - Form 20-F 2019
Report Publication Announcement
2020-03-12 English
ANNUAL REPORT
Annual Report FY 2019
2020-03-12 English
results of the Annual General Meeting of shareholders of the Company, held today, Wednesday, January 29, 2020
AGM Information
2020-01-29 English
results of the Annual General Meeting of shareholders of the Company, held today, Wednesday, January 29, 2020
Report Publication Announcement
2020-01-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-01-29 English
Postponement of annual meeting - No legal quorum
AGM Information
2020-01-22 English
CURRENT REPORT OF FOREIGN ISSUER
Foreign Filer Report
2020-01-22 English
XTL Biopharmaceuticals will hold Annual General Meeting of Shareholders on January 22, 2020
Proxy Solicitation & Information Statement
2020-01-13 English
XTL Biopharmaceuticals will hold Annual General Meeting of Shareholders on January 22, 2020
AGM Information
2020-01-13 English
AMENDMENT NO. 1 TO FORM 6-K
Foreign Filer Report
2020-01-13 English